Skip to main content
. 2018 Dec 14;9:664. doi: 10.3389/fpsyt.2018.00664

Figure 4.

Figure 4

Effect of baclofen on Total SHAS (TSHAS) scores in controls and AD following placebo, 10, 60, or 90 mg baclofen. Data are mean ± S.E.M., expressed as change from baseline. (A) Effect of placebo, 10 and 60 mg baclofen on TSHAS in controls. Repeated measures ANOVA; Dose × Time Interaction: F(12, 96) = 3.20, P = 0.0007. *60 mg > placebo (P < 0.05, Tukey's multiple comparison test). (B) Effect of placebo, 60 and 90 mg baclofen on TSHAS in AD. Repeated measures ANOVA; no significant effect of dose or time, significant dose by time interaction [F(12, 60) = 2.37, P = 0.014], *90 mg > placebo (P < 0.05, Tukey's multiple comparison test). (C) Comparison of the effect of 60 mg baclofen on TSHAS in controls and AD. Mixed ANOVA; significant group effect: F(1, 18) = 6.0, P = 0.025). *60 mg > placebo (P < 0.05, Sidak's multiple comparison test).